Clinical Trial Update: Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma

View source ↗

Summary

This clinical trial is currently recruiting to evaluate the value of PET imaging that targets fibroblast activation protein (FAP) in oral squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• FAPI (Fibroblast activation protein inhibitor)

Snippet

Sponsor: Zhongnan Hospital | Conditions: PET/CT, FAPI | Status: RECRUITING